US Broker Ratings

BioMarin Pharmaceutical Inc. (BMRN): Unveiling a Potential 65% Upside with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading entity in the biotechnology sector, has captured investor attention with its robust development and commercialization of therapies targeting rare, life-threatening diseases. Despite the..

Encompass Health Corporation (EHC): Investor Outlook Reveals a Promising 24.74% Upside

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is attracting significant investor attention. With a market cap of $11.33..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Navigating the 8.74% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a dominant player in the biotechnology sector, continues to present a compelling investment opportunity despite recent fluctuations in its stock price. With a market capitalization..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating a 5.91% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands as a notable player in the healthcare sector, specifically within the specialized arena of drug manufacturing. The company, headquartered in Silver Spring, Maryland, has..

Bristol-Myers Squibb (BMY) Stock Analysis: Is the Healthcare Giant’s 4.76% Dividend Yield a Buying Signal for Investors?

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, stands as a formidable player in the drug manufacturing industry. With a market capitalization of $106.16 billion, the company..

Molina Healthcare Inc (MOH) Stock Analysis: Uncovering a 17.75% Potential Upside in the Healthcare Sector

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare sector, has been on the radar of many investors due to its strategic focus on providing managed healthcare services..

Stryker Corporation (SYK) Stock Analysis: Exploring a 17.94% Potential Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector with a market capitalization of $139.21 billion, stands out as a key player in the medical device industry. Headquartered in..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth Potential with a 20% Revenue Surge

Exact Sciences Corporation (NASDAQ: EXAS) is making waves within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $19.18 billion, the company has established..

Labcorp Holdings Inc. (LH) Stock Analysis: Unlocking a 15.99% Upside Potential in the Healthcare Sector

Labcorp Holdings Inc. (NYSE: LH) is a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $21.47 billion, the company is a significant..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 76% Upside

Investors eyeing opportunities in the healthcare sector may find Summit Therapeutics Inc. (NASDAQ: SMMT) a compelling prospect, especially given the potential upside of 76.41% based on analyst target prices. With..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A 10.6% Upside Potential in Healthcare Innovation

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the medical devices sector, has been capturing investor attention with its robust market presence and promising growth potential. With a..

Fresenius Medical Care AG (FMS): An Investor Outlook with a 26.82% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a formidable player in the healthcare sector, specifically within the medical care facilities industry, presents an intriguing opportunity for investors seeking growth in the..

Insmed Incorporated (INSM) Investor Outlook: Navigating Biotechnology with a 9.20% Potential Upside

Insmed Incorporated (NASDAQ: INSM), a notable player in the biotechnology sector, continues to capture investor attention with its strategic focus on developing therapies for serious and rare diseases. With a..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a Complex Market with Strategic Insights

Illumina, Inc. (NASDAQ: ILMN), a leading player in the healthcare sector’s diagnostics and research industry, is renowned for its sequencing and array-based solutions for genetic and genomic analysis. With a..

Solventum Corporation (SOLV) Stock Analysis: Navigating a Healthcare Innovator with a Strategic Focus

Solventum Corporation (NYSE: SOLV) is a dynamic player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $14.82 billion, Solventum is a formidable presence..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Closer Look at Growth Potential and Analyst Ratings

HCA Healthcare, Inc. (NYSE: HCA), a titan in the medical care facilities industry, is a compelling entity in the healthcare sector. With a market capitalization of $113.88 billion, HCA stands..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 11.59% Potential Upside Amidst Strong Buy Ratings

Tenet Healthcare Corporation (THC), a stalwart in the healthcare sector, commands a significant presence in the United States’ medical care facilities industry with a robust market capitalization of $18.55 billion...

Alnylam Pharmaceuticals (ALNY): Investor Outlook Reveals Strong Revenue Growth and Promising Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player in the biotechnology sector, with a market capitalization of $60.52 billion. The company’s innovative approach to therapeutics, centered on ribonucleic..

Becton, Dickinson and Company (BDX) Stock Analysis: Is a 4.44% Upside Worth Your Investment?

Becton, Dickinson and Company (NYSE: BDX) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $55.59 billion, BDX..

Biogen Inc. (BIIB) Stock Analysis: Evaluating the Investment Potential Amidst a Complex Landscape

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, has long been recognized for its innovative contributions to treating neurological and neurodegenerative..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds